Agilent Technologies Inc. (NYSE: A) has unveiled a new organizational structure aimed at driving higher growth through a market-focused, customer-centric enterprise strategy. The company's new structure, which includes the introduction of new leadership roles, is set to take effect immediately.
The new structure organizes Agilent's businesses according to its end markets and customers, allowing for closer collaboration among the business groups and better execution on cross-division, customer-first priorities. The three new business groups are as follows:
-
Life Sciences and Diagnostics Markets Group (LDG): This group represents 38% of Agilent’s revenue and is primarily focused on the pharma, biopharma, clinical, and diagnostics end markets. The LDG provides a comprehensive portfolio of leading technology platforms and solutions, including liquid chromatography and mass spectrometry instrument platforms, cell and biomolecular analysis, specialized CDMO services, pathology, companion diagnostics, and genomics.
-
Applied Markets Group (AMG): Representing 20% of Agilent’s revenue, this group is primarily focused on the food, environmental, forensics, chemicals, and advanced materials markets. The AMG includes gas chromatography and mass spectrometry, spectroscopy, and vacuum technology platforms.
-
Agilent CrossLab Group (ACG): This group represents the largest share of Agilent’s revenue at 42% and is focused on supporting customers in all end markets. The ACG will accelerate and strengthen customer connections across all Agilent end markets, leveraging its comprehensive portfolio and capabilities, including services, software and informatics, automation, and consumables.
The leadership of these business groups includes Simon May as President of LDG, Mike Zhang as President of AMG, and Angelica Riemann continuing as President of ACG.
Agilent will share additional details about the company’s market-focused, customer-first enterprise strategy and transformation at its analyst and investor day on December 17, 2024. The company will also be releasing its fourth-quarter fiscal 2024 financial results later today under the existing fiscal year 2024 organizational structure. However, the first-quarter 2025 results will be reported under the new organizational structure.
Agilent will issue an 8-K before the analyst and investor day with a recast of the previous three years of financial reporting to reflect the new structure. Additionally, a recast 10-K reflecting the new structure will be released in March 2025. Following these announcements, the company's shares moved 1.1%, and are now trading at a price of $135.34. If you want to know more, read the company's complete 8-K report here.
